About

MD: UT Southwestern, Dallas, TX, 1993.

Residency: Children's Hospital of Dallas, Dallas, TX, 1996.

Fellowship: The Children's Hospital, Denver, CO, 2002.

Certification: American Board of Pediatrics, 1996; Sub-board of Pediatric Heme/Onc, 2002.

Interests

Histiocytic disorders: HLH and LCH

Services and Specialties

Cancer and Blood Diseases, Immune Deficiencies and Histiocytosis, Bone Marrow Transplantation BMT, Leukemia, Hemophagocytic lymphohistiocytosisHLH, Histiocytosis Center, Autoimmune Liver Disease, Rare Lung Diseases

Interests

Better understanding histiocytic disorders and developing novel therapies for them; regulation of the immune response; immunotherapy of cancer

Research Areas

Bone Marrow Transplantation and Immune Deficiency, Cancer and Blood Diseases, Immunobiology

Insurance Information

Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.

View Insurance Information

Publications

Real-world treatment patterns and outcomes in patients with primary hemophagocytic lymphohistiocytosis treated with emapalumab. Chandrakasan, S; Jordan, MB; Baker, A; Behrens, EM; Bhatla, D; Chien, M; Eckstein, OS; Henry, MM; Hermiston, ML; Hinson, AP; Walkovich, KJ; Yee, JD; Zoref-Lorenz, A; Allen, CE. Blood Advances. 2024; 8:2248-2258.

COVID-19 Vaccination in Patients with Inborn Errors of Immunity Reduces Hospitalization and Critical Care Needs Related to COVID-19: a USIDNET Report. McDonnell, J; Cousins, K; Younger, ME M; Lane, A; Abolhassani, H; Abraham, RS; Al-Tamemi, S; Aldave-Becerra, JC; Al-Faris, EH; Alfaro-Murillo, A; Lim, XR; Lopes, JP; López, AL; Tarquini, L. Journal of Clinical Immunology. 2024; 44:86.

68 LRBA dysfunction: a new diagnostic entity caused by biallelic LRBA missense variants results in reduced CTLA-4 expression and autoimmunity. Chiang, S; Murguia-Favela, L; Wright, N; Steele, M; Seroogy, C; Blanchard-Rohner, G; Shrikhande, A; Wilson, J; Yang, L; Owsley, E; Derfalvi, B; Brager, R; Jordan, M; Marwaha, A. Clinical Immunology. 2024; 262:110010.

Dabrafenib and trametinib in Langerhans cell histiocytosis and other histiocytic disorders. Cournoyer, E; Ferrell, J; Sharp, S; Ray, A; Jordan, M; Dandoy, C; Grimley, M; Roy, S; Lorsbach, R; Merrow, AC; Nelson, A; Bartlett, A; Picarsic, J; Kumar, A. Haematologica: the hematology journal. 2024; 109:1137-1148.

Survival in primary hemophagocytic lymphohistiocytosis, 2016 to 2021: etoposide is better than its reputation. Böhm, S; Wustrau, K; Pachlopnik Schmid, J; Prader, S; Ahlmann, M; Yacobovich, J; Beier, R; Speckmann, C; Behnisch, W; Ifversen, M; Lindemans, C; Henter, JI; Lehmberg, K; Ehl, S. Blood. 2024; 143:872-881.

Hemophagocytic lymphohistiocytosis: A disorder of T cell activation, immune regulation, and distinctive immunopathology. Jordan, MB. Immunological Reviews. 2024; 322:339-350.

Emapalumab Therapy Prior to Hematopoietic Stem Cell Transplant Is Associated with Improved Long-Term Chimerism and Event-Free Survival in Pediatric Patients with Hemophagocytic Lymphohistiocytosis. Verkamp, B; Jodele, S; Marsh, RA; Sabulski, DA; Davies, SM; Jordan, MB. Transplantation and Cellular Therapy. 2024; 30:s93.

Exposure-safety relationship for patients with primary hemophagocytic lymphohistiocytosis treated with emapalumab. Jordan, MB; Locatelli, F. Pediatric Blood and Cancer. 2024; 71:e30778.

Hemophagocytic Lymphohistiocytosis in the Context of Hematological Malignancies and Solid Tumors. Zoref-Lorenz, A; Lehmberg, K; Jordan, M. Advances in Experimental Medicine and Biology. 2024; 1448:429-440.

Here be dragons: A universal profile of recent T-cell (hyper)activation?. Jordan, MB. Journal of Allergy and Clinical Immunology. 2024; 153:98-99.

Patient Ratings and Comments

All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey

4.6
Overall Patient Rating